Your browser doesn't support javascript.
loading
Efficacy and Safety of Regdanvimab (CT-P59): A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Trial in Outpatients With Mild-to-Moderate Coronavirus Disease 2019.
Streinu-Cercel, Anca; Sandulescu, Oana; Preotescu, Liliana-Lucia; Kim, Jin Yong; Kim, Yeon-Sook; Cheon, Shinhye; Jang, Young Rock; Lee, Sang Joon; Kim, Sung Hyun; Chang, Ilsung; Suh, Jee Hye; Lee, Seul Gi; Kim, Mi Rim; Chung, Da Rae; Kim, Han Na; Streinu-Cercel, Adrian; Eom, Joong Sik.
Afiliación
  • Streinu-Cercel A; National Institute for Infectious Diseases "Prof. Dr. Matei Balș," Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
  • Sandulescu O; National Institute for Infectious Diseases "Prof. Dr. Matei Balș," Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
  • Preotescu LL; National Institute for Infectious Diseases "Prof. Dr. Matei Balș," Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
  • Kim JY; Division of Infectious Diseases, Department of Internal Medicine, Incheon Medical Center, Incheon, Republic of Korea.
  • Kim YS; Division of Infectious Diseases, Chungnam National University School of Medicine, Daejeon, Republic of Korea.
  • Cheon S; Division of Infectious Diseases, Chungnam National University School of Medicine, Daejeon, Republic of Korea.
  • Jang YR; Division of Infectious Diseases, Department of Internal Medicine, Incheon Medical Center, Incheon, Republic of Korea.
  • Lee SJ; Celltrion, Inc., Incheon, Republic of Korea.
  • Kim SH; Celltrion, Inc., Incheon, Republic of Korea.
  • Chang I; Celltrion, Inc., Incheon, Republic of Korea.
  • Suh JH; Celltrion, Inc., Incheon, Republic of Korea.
  • Lee SG; Celltrion, Inc., Incheon, Republic of Korea.
  • Kim MR; Celltrion, Inc., Incheon, Republic of Korea.
  • Chung DR; Celltrion, Inc., Incheon, Republic of Korea.
  • Kim HN; Celltrion, Inc., Incheon, Republic of Korea.
  • Streinu-Cercel A; National Institute for Infectious Diseases "Prof. Dr. Matei Balș," Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
  • Eom JS; Division of Infectious Diseases, Gil Medical Center, Gachon University College of Medicine, Incheon, Republic of Korea.
Open Forum Infect Dis ; 9(4): ofac053, 2022 Apr.
Article en En | MEDLINE | ID: mdl-35295819
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Open Forum Infect Dis Año: 2022 Tipo del documento: Article País de afiliación: Rumanía
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Open Forum Infect Dis Año: 2022 Tipo del documento: Article País de afiliación: Rumanía